However, Ramirez et al. observed that monocytoid AML patients show higher CCR2 expression, but significantly lower levels of CCL2 production compared to other AML subgroups and to normal controls [61], suggesting that the CCL2-CCR2 axis might be of particular relevance in this subset of patients. The gene discussed is CCR2; the disease is acute myeloid leukemia.